Filing Flows › Pediatrix Medical Group (MD) › Capital expenditures
Pediatrix Medical Group (MD) capital expenditures by quarter
Pediatrix Medical Group's capital expenditures were $4.4M in Q3 2026 (third quarter 2026), +218% from Q2 2026. Over the last 5 quarters it ranged from $1.4M (Q2 2026) to $5.3M (Q3 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $4.4M | +218% | -18% |
| Q2 2026 | $1.4M | -74% | -69% |
| Q4 2025 | $5.3M | -1% | — |
| Q3 2025 | $5.3M | +18% | — |
| Q2 2025 | $4.5M | — | — |
Q3 2026 at a glance
Pediatrix Medical Group, Q3 2026: revenue $501M (+2% year over year), operating margin 13.0%, net earnings $47.0M, operating cash flow $117M. The chart follows the revenue to costs, profit and cash.
Questions
What is Pediatrix Medical Group's capital expenditures?
Pediatrix Medical Group's capital expenditures were $4.4M in Q3 2026 (third quarter 2026), +218% from Q2 2026.
How has Pediatrix Medical Group's capital expenditures changed?
Over the last 5 quarters it ranged from $1.4M (Q2 2026) to $5.3M (Q3 2025).
Q3 2026 results → · How Pediatrix Medical Group makes money →